查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球蛋白质测定市场——行业规模、份额、趋势、竞争、机会、预测、按类型、按产品、按技术、按应用、按最终用户、按地区、按竞争对手分析 (2018-2028)
市场调查报告书
商品编码
1244134

全球蛋白质测定市场——行业规模、份额、趋势、竞争、机会、预测、按类型、按产品、按技术、按应用、按最终用户、按地区、按竞争对手分析 (2018-2028)

Protein Assays Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Type, By Product, By Technology, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球蛋白质分析市场将在 2024 年至 2028 年的预测期内经历强劲增长。

这一市场增长的主要驱动力是在蛋白质组学领域开展的严格研究和开发。 例如，2022 年 6 月，班加罗尔印度科学研究所 (IISc) 的一些科学家开发了一种全新的合成□，称为微型蛋白质。 据几位研究人员称，这些微型蛋白可以中和 SARS-CoV-2 样病毒。 更重要的是，根据《自然化学生物学》杂誌的报导，这些微型蛋白已被证明能够阻止病毒进入宿主细胞。 它还可以捆绑病毒颗粒以降低它们引起感染的能力。 此类研究进展可能对全球蛋白质分析市场的增长产生积极影响。

用于癌症诊断的蛋白质检测

蛋白质分析为疾病诊断、分类和监测提供了机会。 必须满足某些要求才能使测定在治疗上有用。 首先，您需要能够检测您感兴趣的蛋白质。 检测必须对待□□检测的蛋白质敏感且特异。 此外，为了使这些测试有效，它们必须使用现成的患者样本。 此外，实验室工作人员必须接受适当的培训才能执行这些过程，并且在临床环境中必须随时可以使用化验设备。 此外，化验必须在劳动力和成本方面高效，并且足够稳健以生成跨实验室和员工的可比较数据。

许多基于流式细胞术、□联免疫吸附测定 (ELISA) 和免疫组织化学 (IHC) 的蛋白质测定用于癌症检测、预后和治疗。 这些方法可以检测 100 多种独特的蛋白质，但并非所有蛋白质都与癌症有关。 免疫组织化学是检测乳腺癌患者 Her2 标誌物和雌激素受体最合适的方法。 ELISA 是另一种识别血液中癌症生物标誌物的重要方法。 该方法可以同时检测多种标记物，具有很高的特异性和灵敏度。 例如，针对卵巢癌开发的 6 标记 ELISA 报告的特异性为 99.4%，灵敏度为 95.3%。

因此，全球范围内越来越多的癌症病例及其检测可能会显着扩大全球蛋白质检测市场。

蛋白质组学研究的政府资助

许多政府提供资金支持蛋白质组学领域的新研究和开发。 例如，印度政府的印度医学研究委员会 (ICMR) 向生物信息学研究所 (IOB) 和 ICMR-Regional Medical Research Centre, NE region, Dibrugarh 发表了一份声明，题为“Proteomics and biochemical analysis for identification用于预测的新型生物标誌物的研究 我们资助了“妊娠高血压综合征 (PIH)：来自 Dibrugarh 的健康和人口统计学队列”项目。IOB 对具有特征的晚期妊娠妇女的尿液样本进行了蛋白质分析。该项目的主要目标是开发及时检测妊娠高血压综合征的蛋白标誌物。

此外，临床蛋白质组学肿瘤分析联盟 (CPTAC) 启发了美国国家癌症研究所 (NCI) 的小企业创新研究 (SBIR) 发展中心于 2020 年 8 月宣布的资助。 该演示文稿呼吁开发高通量单细胞蛋白质组发现技术。 这个机会旨在促进我们对癌症如何开始和扩散的理解，以及促进在微尺度上发现和临床使用强大的癌症生物标誌物。

此外，Genome Canada 和 Genome BC 在 2018 年为蛋白质研究提供了超过 180,000 美元的资金。 这笔资金导致了针对各种疾病的新型诊断和治疗方法的开发。

这些发现可以为全球蛋白质分析市场提供有利可图的机会。

近期发展

  • PerkinElmer 是一家医疗生命科学公司，于 2022 年 4 月推出了两款检测试剂盒，分别名为均相时间分辨荧光 (HTRF) 和 AlphaLISA。 这些试剂盒用于及时检测和定量中国仓鼠卵巢 (CHO) 宿主细胞蛋白 (HCP) 杂质。
  • 领先的蛋白质组学公司 Biognosys 于 2022 年 3 月推出了其蛋白质组学平台，为製药和诊断公司提供用于研发的生物学理解。
  • Eli Lilly and Company 于 2021 年 7 月收购了 Protomar Technologies。
  • GeoMx DSP Protein Assays 由生物技术公司 NanoString Technologies, Inc. 于 2020 年 11 月推出。

市场细分

全球蛋白质分析市场根据类型、产品、技术、应用、最终用户和地区进行细分。 按类型，它们分为染料结合测定、基于试纸的测定、基于铜离子的测定等。 按产品分类，分为试剂、试剂盒和仪器/附件。 按照技术，它们分为量热蛋白测定、荧光蛋白测定和吸光度蛋白测定。 按应用分为药物发现与开发、疾病诊断等。 基于最终用户，市场进一步细分为製药和生物技术公司、临床实验室、医院、学术研究机构等。

公司简介

全球蛋白质分析市场的主要参与者包括 Becton Dickinson and Co、Thermo Fisher Scientific Inc、Bio-Rad Laboratories Inc、Merck KGaA、Abcam PLC、PerkinElmer Inc、QIAGEN NV、Lonza Group AG、Bio-Techne Corp、Illumina公司等。

报告范围：

本报告将全球蛋白质分析市场分为以下几类，行业趋势详述如下：

蛋白质测定市场，按类型

  • 染料结合分析
  • 基于试纸的检测
  • 使用铜离子进行检测
  • 其他

蛋白质测定市场，按产品分类：

  • 试剂
  • 工具包
  • 设备和配件

蛋白质检测市场，按技术分类：

  • 蛋白质比色法
  • 使用荧光的蛋白质测定方法
  • 基于吸光度的蛋白质测定

蛋白质检测市场，按应用：

  • 药物发现和开发
  • 疾病诊断
  • 其他

最终用户的蛋白质测定市场：

  • 製药公司、生物技术公司
  • 临床实验室
  • 医院
  • 学术研究机构
  • 其他

按地区划分的蛋白质测定市场：

  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚
  • 欧洲
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙
  • 北美
    • 美国
    • 墨西哥
    • 加拿大
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东和非洲
    • 南非
    • 沙特阿拉伯
    • 阿联酋

竞争格局

公司概况：对全球蛋白质分析市场主要参与者的深入分析。

可自定义：

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

  • 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析

内容

第 1 章概述

  • 市场定义
  • 市场范围
    • 目标市场
    • 研究目标年份
    • 主要市场细分

第二章研究方法论

  • 调查目的
  • 基线调查方法
  • 主要行业合作伙伴
  • 主要协会和次要信息
  • 调查方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章执行摘要

  • 市场概览
  • 主要市场细分概述
  • 主要市场参与者概览
  • 主要地区/国家概览
  • 市场驱动因素、挑战和趋势概述

第 4 章 VOC（客户之声）

第5章临床试验分析

  • 正在进行的临床试验
  • 已完成临床试验
  • 已完成临床试验
  • 管道细分（按开发阶段）
  • 管道细分（按状态
  • 管道分解（按测试应用）
  • 按地区划分的渠道细分
  • 临床试验热图

第六章专利分析

第 7 章蛋白质检测的全球市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 按技术（比色蛋白质测定、荧光蛋白质测定、吸光度蛋白质测定）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按地区
    • 按公司分类（2022 年）
  • 产品市场地图
    • 按类型
    • 按产品分类
    • 按技术
    • 通过申请
    • 最终用户
    • 按地区

第 8 章亚太地区蛋白质检测市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 通过技术（比色法、荧光法、吸收法）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按国家
  • 亚太地区：国家/地区分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 9 章欧洲蛋白质分析市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 通过技术（比色法、荧光法、吸收法）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按国家
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 10 章北美蛋白质分析市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 通过技术（比色法、荧光法、吸收法）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按国家
  • 北美：国家/地区分析
    • 美国
    • 墨西哥
    • 加拿大

第11章南美蛋白质分析市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 通过技术（比色法、荧光法、吸收法）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按国家
  • 南美洲：：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 12 章中东和非洲蛋白质测定市场展望

  • 市场规模和预测
    • 按价值观
  • 市场份额和预测
    • 按类型（染料结合测定、基于试纸的测定、基于铜离子的测定等）
    • 按产品（试剂、试剂盒、仪器、配件）
    • 按技术（比色蛋白质测定、荧光蛋白质测定、吸光度蛋白质测定）
    • 按应用（药物发现/开发、疾病诊断等）
    • 最终用户（製药公司、生物技术公司、临床实验室、医院、学术研究机构等）
    • 按国家
  • MEA：国家分析
    • 南非蛋白质测定
    • 沙特阿拉伯蛋白质检测
    • 阿联酋蛋白质分析

第 13 章市场动态

  • 司机
    • 蛋白质组学研究进展
    • 增加政府资助
    • 通过蛋白质分析检测癌症
  • 做
    • 严格的监管框架
    • 缺乏熟练的专业人员
    • 蛋白质分析开发中的挑战

第十四章市场趋势与发展

  • 化验装置的小型化
  • 生物标誌物的进展
  • 新产品发布次数增加

第15章竞争格局

  • Business Overview
  • Company Snapshot
  • Products & Services
  • Financials（As Reported）
  • Recent Developments
  • SWOT Analysis
    • Becton Dickinson and Co
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories Inc
    • Merck KGaA
    • Abcam PLC
    • PerkinElmer Inc.
    • QIAGEN NV
    • Lonza Group AG
    • Bio-Techne Corp
    • Illumina Inc

第16章 战略建议

简介目录
Product Code: 7415

Global protein assays market will undergo vigorous growth in the forecast period, 2024-2028. The principal factor behind this market growth is the rigorous research and development taking place in proteomics. For example, a brand-new category of synthetic peptides, better known as mini proteins, was developed by some scientists working at the Indian Institute of Science (IISc), Bangalore in June 2022. According to a few researchers, these mini proteins have the potential to neutralize SARS-CoV-2-like viruses. Moreover, based on work from the journal Nature Chemical Biology, it has come into the picture that these mini proteins can inhibit the virus from entering the host cell. Also, they can clutch the virus particles together to deteriorate their ability to cause infection. This progress in research can positively impact the growth of the global protein assay market.

During the forecast period, the market expansion is going to be supported by increased expenditures made by leading players in the development of cutting-edge & efficient medications & diagnostic instruments. For instance, Bruker Corp. introduced the two new timsTOF instruments in June 2021. It makes new techniques and uses possible, such as the unbiased, deep multi-omic biomarker discovery process and epi proteomics/PTM characterization. Additionally, they further develop & facilitate these cutting-edge applications & techniques in cancer liquid biopsy research.

Protein Assays for Cancer Diagnosis

Opportunities for disease diagnosis, classification, and monitoring are provided by protein analysis. An assay must fulfill specific requirements to be therapeutically relevant. To begin with, it must be capable of detecting the desired protein or proteins. An assay also needs to be specific to the protein it is meant to detect in addition to being sensitive. These tests must also work with readily accessible patient samples to be effective. Additionally, laboratory staff must be properly trained to carry out these processes, and the assay's equipment must be easily obtainable in clinical settings. Moreover, assays must be efficient in terms of labor and cost, as well as robust enough to produce data that can be compared across laboratories and staff.

Numerous protein assays based on flow cytometry, enzyme-linked immunosorbent assay (ELISA), and immunohistochemistry (IHC) are employed for the detection, prognosis, and treatment of cancer. These methods can detect over 100 distinctive proteins (not all cancer related). Immunohistochemistry has found its best application in detecting Her2 marker and estrogen receptors in patients with breast cancer. ELISA is another remarkable method to identify cancer biomarkers in blood. This method can detect several markers at the same time with high specificity and sensitivity. For instance, 99.4% specificity and 95.3% sensitivity were reported from a six-marker ELISA developed for ovarian cancer.

Therefore, the increasing number of cancer cases across the globe and their detection can escalate the global protein assay market considerably.

Government Funding for Research in Proteomics

Governments of quite a few countries are offering funding to assist new research and development in the field of proteomics. For example, the Indian Council of Medical Research (ICMR), Government of India provided funding to the Institute of Bioinformatics (IOB) as well as ICMR-Regional Medical Research Centre, NE region, Dibrugarh for a project named "Proteomics and biochemical analysis for identification of novel biomarkers for predicting pregnancy-induced hypertension (PIH): In a health and demographic cohort from Dibrugarh." The IOB will be conducting protein analysis of urine samples of pregnant women in distinctive trimesters. The chief aim of this project is to develop a protein marker for the timely detection of PIH.

Furthermore, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) served as an inspiration for funding that was announced by the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) Development Center in August 2020. The announcement calls for the development of high-throughput single-cell proteome discovery technologies. This opportunity aims to improve our understanding of how cancer begins and spreads while also facilitating the discovery of powerful cancer biomarkers and their clinical utilization on a micro-scale.

In addition, Genome Canada and Genome BC offered a funding amount of over 18 million for protein research in the year 2018. This funding resulted in the development of novel diagnostic and treatment approaches for different diseases.

These findings can offer lucrative opportunities for the global protein assay market.

Recent Developments

  • A medical life science company, PerkinElmer, Inc. launched two assay kits named homogenous time-resolved fluorescence (HTRF) and AlphalLISA in April 2022. These kits are meant for the timely detection and quantification of Chinese hamster ovary (CHO) host cell protein (HCP) impurities.
  • A proteomic platform, providing biological understanding for research and development to the pharmaceutical as well as diagnostic firms was launched by a leading proteomics company, Biognosys in March 2022.
  • Eli Lilly and Company acquired Protomer Technologies in July 2021.
  • GeoMx DSP Protein Assays was launched by NanoString Technologies, Inc., a biotech company in November 2020.

Market Segmentation

Global protein assay market is segmented based on type, product, technology, application, end-user, and region. Based on type, the market is categorized into dye-binding assays, test strip-based assays, copper-ion-based assays, and others. Based on product, the market is divided into reagents, kits, and instruments & accessories. Based on technology, the market is fragmented into calorimetric protein assays, fluorescence-based protein assays, and absorbance-based protein assays. Based on application, the market can be divided into drug discovery and development, disease diagnosis, and others. Based on end users, the market can be further segmented into pharmaceutical and biotechnology companies, clinical laboratories, hospitals, academic research institutes, and others.

Company Profiles

The major players in the global protein assays market are Becton Dickinson and Co, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Merck KGaA, Abcam PLC, PerkinElmer Inc., QIAGEN NV, Lonza Group AG, Bio-Techne Corp, Illumina Inc, among others.

Report Scope:

In this report, global protein assays market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Assays Market, By Type:

  • Dye Binding Assays
  • Test Strip-Based Assays
  • Copper-Ion-Based Assays
  • Others

Protein Assays Market, By Product:

  • Reagents
  • Kits
  • Instruments and Accessories

Protein Assays Market, By Technology:

  • Colorimetric Protein Assays
  • Fluorescence-Based Protein Assays
  • Absorbance-Based Protein Assays

Protein Assays Market, By Application:

  • Drug Discovery and Development
  • Disease Diagnosis
  • Others

Protein Assays Market, By End User:

  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • Hospitals
  • Academic Research Institutes
  • Others

Protein Assays Market, By Region:

  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • North America
    • United States
    • Mexico
    • Canada
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global protein assays market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Clinical Trial Analysis

  • 5.1. Ongoing Clinical Trials
  • 5.2. Completed Clinical Trials
  • 5.3. Terminated Clinical Trials
  • 5.4. Breakdown of Pipeline, By Development Phase
  • 5.5. Breakdown of Pipeline, By Status
  • 5.6. Breakdown of Pipeline, By Study Application
  • 5.7. Breakdown of Pipeline, By Region
  • 5.8. Clinical Trials Heat Map

6. Patents Analysis

7. Global Protein Assays Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 7.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 7.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 7.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 7.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 7.2.6. By Region
    • 7.2.7. By Company (2022)
  • 7.3. Product Market Map
    • 7.3.1. By Type
    • 7.3.2. By Product
    • 7.3.3. By Technology
    • 7.3.4. By Application
    • 7.3.5. By End User
    • 7.3.6. By Region

8. Asia-Pacific Protein Assays Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 8.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 8.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 8.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 8.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Protein Assays Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Protein Assays Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Protein Assays Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Protein Assays Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Protein Assays Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Europe Protein Assays Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 9.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 9.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 9.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 9.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 9.2.6. By Country
  • 9.3. Europe: Country Analysis
    • 9.3.1. France Protein Assays Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Germany Protein Assays Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. United Kingdom Protein Assays Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User
    • 9.3.4. Italy Protein Assays Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type
        • 9.3.4.2.2. By Product
        • 9.3.4.2.3. By Technology
        • 9.3.4.2.4. By Application
        • 9.3.4.2.5. By End User
    • 9.3.5. Spain Protein Assays Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Type
        • 9.3.5.2.2. By Product
        • 9.3.5.2.3. By Technology
        • 9.3.5.2.4. By Application
        • 9.3.5.2.5. By End User

10. North America Protein Assays Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 10.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 10.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 10.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 10.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 10.2.6. By Country
  • 10.3. North America: Country Analysis
    • 10.3.1. United States Protein Assays Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Mexico Protein Assays Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Canada Protein Assays Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. South America Protein Assays Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 11.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 11.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 11.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 11.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 11.2.6. By Country
  • 11.3. South America: Country Analysis
    • 11.3.1. Brazil Protein Assays Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Type
        • 11.3.1.2.2. By Product
        • 11.3.1.2.3. By Technology
        • 11.3.1.2.4. By Application
        • 11.3.1.2.5. By End User
    • 11.3.2. Argentina Protein Assays Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Type
        • 11.3.2.2.2. By Product
        • 11.3.2.2.3. By Technology
        • 11.3.2.2.4. By Application
        • 11.3.2.2.5. By End User
    • 11.3.3. Colombia Protein Assays Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Type
        • 11.3.3.2.2. By Product
        • 11.3.3.2.3. By Technology
        • 11.3.3.2.4. By Application
        • 11.3.3.2.5. By End User

12. Middle East and Africa Protein Assays Market Outlook

  • 12.1. Market Size & Forecast
    • 12.1.1. By Value
  • 12.2. Market Share & Forecast
    • 12.2.1. By Type (Dye Binding Assays, Test Strip-Based Assays, Copper-Ion-Based Assays, Others)
    • 12.2.2. By Product (Reagents, Kits, Instruments and Accessories)
    • 12.2.3. By Technology (Colorimetric Protein Assays, Fluorescence-Based Protein Assays, Absorbance-Based Protein Assays)
    • 12.2.4. By Application (Drug Discovery and Development, Disease Diagnosis, Others)
    • 12.2.5. By End User (Pharmaceutical and Biotechnology Companies, Clinical Laboratories, Hospitals, Academic Research Institutes, Others)
    • 12.2.6. By Country
  • 12.3. MEA: Country Analysis
    • 12.3.1. South Africa Protein Assays Market Outlook
      • 12.3.1.1. Market Size & Forecast
        • 12.3.1.1.1. By Value
      • 12.3.1.2. Market Share & Forecast
        • 12.3.1.2.1. By Type
        • 12.3.1.2.2. By Product
        • 12.3.1.2.3. By Technology
        • 12.3.1.2.4. By Application
        • 12.3.1.2.5. By End User
    • 12.3.2. Saudi Arabia Protein Assays Market Outlook
      • 12.3.2.1. Market Size & Forecast
        • 12.3.2.1.1. By Value
      • 12.3.2.2. Market Share & Forecast
        • 12.3.2.2.1. By Type
        • 12.3.2.2.2. By Product
        • 12.3.2.2.3. By Technology
        • 12.3.2.2.4. By Application
        • 12.3.2.2.5. By End User
    • 12.3.3. UAE Protein Assays Market Outlook
      • 12.3.3.1. Market Size & Forecast
        • 12.3.3.1.1. By Value
      • 12.3.3.2. Market Share & Forecast
        • 12.3.3.2.1. By Type
        • 12.3.3.2.2. By Product
        • 12.3.3.2.3. By Technology
        • 12.3.3.2.4. By Application
        • 12.3.3.2.5. By End User

13. Market Dynamics

  • 13.1. Drivers
    • 13.1.1. Increasing Research in Proteomics
    • 13.1.2. Increasing Government Fundings
    • 13.1.3. Cancer Detection with Protein Assays
  • 13.2. Challenges
    • 13.2.1. Stringent Regulatory Framework
    • 13.2.2. Dearth of Skilled Professionals
    • 13.2.3. Issue Regarding the Development of Protein Assays

14. Market Trends & Developments

  • 14.1. Miniaturization of Assay Equipment
  • 14.2. Advancements in Biomarker
  • 14.3. Increasing Launches of New Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (As Reported)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Becton Dickinson and Co
    • 15.6.2. Thermo Fisher Scientific Inc.
    • 15.6.3. Bio-Rad Laboratories Inc
    • 15.6.4. Merck KGaA
    • 15.6.5. Abcam PLC
    • 15.6.6. PerkinElmer Inc.
    • 15.6.7. QIAGEN NV
    • 15.6.8. Lonza Group AG
    • 15.6.9. Bio-Techne Corp
    • 15.6.10. Illumina Inc

16. Strategic Recommendations